Program

Program at a glance

 Program at a glance

Live Streaming Distribution

 Program
Thursday, September 23  Program
Friday, September 24  Program
Saturday, September 25

On-demand Distribution

 Educational Lecture
Thursday, September 23
- Friday, October 15 Poster Session
Thursday, September 23
- Saturday, September 25

To read the PDF file you will need Adobe Reader installed on your computer.

as of September 30, 2021

Ⓔ = English Session

<Live Streaming Distribution>

Presidential LectureLive Recording On-demand

Thursday, September 23 13:30-14:00No.1

Iron, heme, and erythropoiesis

Chair：

Akira Miura
(Professor emeritus of Akita University)

Speaker：

Hideo Harigae
(Dep., Hematol., Rheumatol., Tohoku Univ., Sendai, Japan)

JSH Award LectureLive Recording On-demand

Saturday, September 25 13:10-13:50 No.1

Hematopoiesis andblood cancers

Chair：

Itaru Matsumura
(Depertment of Hematology and Rheumatology, Kindai University Faculty of Medicine)

Speaker：

Shigeru Chiba
(Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan)

Ⓔ Plenary Session

Friday, September 24 13:10-14:10 No.1

Chair：

Akifumi Takaori-Kondo
(Department of Hematology/Oncology, Graduate School of Medicine, Kyoto University)
Hitoshi Kiyoi
(Department of Hematology and Oncology, Nagoya University Graduate School of Medicine)

A novel YAP/TAZ activator preserves bone marrow environment and promotes hematopoietic regeneration

Speaker：

Shun Uemura
(Institute of Medical Science, The University of Tokyo, Tokyo, Japan)

CTX-712, a novel CLK inhibitor targeting myeloid neoplasms with SRSF2 mutation

Speaker：

Akinori Yoda
(Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan)

IDH2 mutant AML cells utilize phospholipid metabolic adaptation for apoptosis resistance

Speaker：

Tatsuya Morishima
(Laboratory of Stem Cell Stress, IRCMS, Kumamoto University, Kumamoto, Japan)

Myeloid/natural killer (NK) cell precursor acute leukemia as a novel distinctive leukemia entity

Speaker：

Akira Nishimura
(Pediatr. Dev. Biol., TMDU, Tokyo, Japan)

Identification of transcriptional features & surface markers of plasma cell clones in POEMS syndrome

Speaker：

Yusuke Isshiki
(Department of Hematology, Chiba University Hospital, Japan)

Genome-wide CRISPR-Cas9 screening to identify the genes regulating human CAR-T cells proliferation

Speaker：

Yoshitaka Adachi
(Hemaology and Oncology, Nagoya Univ., Nagoya, Japan)

Special LectureLive Recording On-demand

Ⓔ Special Lecture 1

Thursday, September 23 11:15-12:00 No.1

Biology to therapy in the hematopoietic niche

Chair：

Koichi Akashi
(Kyushu University)

Speaker：

David Scadden
(Harvard University and Massachusetts General Hospital, USA)

Ⓔ Special Lecture 2

Saturday, September 25 11:05-11:50 No.1

Systemic iron homeostasis: hormones, pathways, diseases

Chair：

Hideo Harigae
(Dep., Hematol., Rheumatol., Tohoku Univ., Sendai, Japan)

Speaker：

Tomas Ganz
(Depts. of Medicine and Pathology, UCLA, Los Angeles, USA)

Ⓔ ASH Special LectureLive Recording On-demand

Friday, September 24 11:15-12:00 No.1

Use of patient-reported outcomes in clinical care and research

Chair：

Kinuko Mitani
(Department of Hematology and Oncology, Dokkyo Medical University)

Speaker：

Stephanie J. Lee
(Fred Hutchinson Cancer Research Center(FHCRC)and University of Washington (UW), Seattle, WA, USA)

Ⓔ EHA Special LectureLive Recording On-demand

Thursday, September 23 14:00-14:45 No.1

Immature T lymphoid malignancies: frontier states

Chair：

Takanori Teshima
(Department of Hematology, Hokkaido University Graduate School of Medicine)

Speaker：

Elizabeth Macintyre
(Hôpital Necker - Enfants Malades laboratoire onco-hématologie, France)

Ⓔ Presidential SymposiumLive Recording On-demand

Thursday, September 23 9:00-11:00 No.1

The Path from Stem Cells to Red Blood Cells

Chair：

Hideo Harigae
(Dep., Hematol., Rheumatol., Tohoku Univ., Sendai, Japan)
Takahiro Suzuki
(Department of Hematology, Kitasato University School of Medicine)

Speaker：

Merav Socolovsky
(University of Massachusetts Medical School, USA)
Clara Camaschella
(Division of Genetics and Cell Biology, San Raffaele Scientific Institute, Milano, Italy)
Masayuki Yamamoto
(Med. Biochem., Tohoku Univ., Sendai, Japan)
Hiroki Kato
(Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan)

Ⓔ Asian Joint Panel DiscussionLive Recording On-demand

Thursday, September 23 15:00-17:00 No.3

Virus-Associated Lymphoid Malignancies in Asian Countries

Chair：

Kazuya Shimoda
(University of Miyazaki)
Wen-Chien Chou
(National Taiwan University Hospital, Taipei, Taiwan)

Speaker：

Changiu Qu
(National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China)
Chieh-Lung Cheng
(Attending Physician, Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan)
Udomsak Bunworasate
(Division of Hematology, Department of Medicine, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Thailand)
Dok Hyun Yoon
(Asan Medical Center, University of Ulsan College of Medicine, Korea)
Pankaj Malhotra
(Clinical Hematology and BMT unit, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India)
Ng Siok Bian
(Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore)
Takuya Fukushima
(Laboratory of Hematoimmunology, School of Health Sciences, Univ. of the Ryukyus, Japan)

Special SymposiumLive Recording On-demand

Friday, September 24 15:00-17:00 No.1

The Post-Covid Society

Chair：

Itaru Matsumura
(Depertment of Hematology and Rheumatology, Kindai University Faculty of Medicine)
Yasushi Miyazaki
(Atomic Bomb Disease Institute, Nagasaki University)

Speaker：

Hitoshi Oshitani
(Department of Virology, Tohoku University, Graduate School of Medicine)
Goichiro Toyoda
(Medley, Inc)
Yozo Tachibana
(Rakuten Baseball, Inc)
Robert Campbell
(University Professor, Waseda University)

SymposiumLive Recording On-demand

Ⓔ Symposium 1

Thursday, September 23 9:00-11:00 No.2

Molecular Pathogenesis and Targeting Agents in AML

Chair：

Seishi Ogawa
(Graduate School of Medicine, Kyoto University)
Fumihiko Ishikawa
(RIKEN)

Speaker：

Richard Stone
(Chief of Staff, Dana-Farber Cancer Institute, Professor of Medicine, Harvard Medical School, USA)
Koichi Takahashi
(Leukemia Department, The University of Texas MD Anderson Cancer Center)
Craig Jordan
(University of Colorado, USA)
Ryosaku Inagaki
(Dept. of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan)
Takahiro Ito
(Inst Front Life Med Sci., Kyoto Univ., Kyoto, Japan)

Ⓔ Symposium 2

Thursday, September 23 9:00-11:00 No.3

Molecular Mechanism of Inflammation and Tumor in Histiocytic Disorders

Chair：

Yoko Shioda
(National Center for Child Health and Development, Childrenʼs Cancer Center)
Shouichi Ohga
(Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University)

Speaker：

Arinobu Tojo
(Inst Innov Adv., Tokyo Med Den Univ., Tokyo, Japan)
Yasutaka Okabe
(Osaka University, Osaka, JAPAN)
Akira Morimoto
(Department of Pediatrics, Jichi Medical University School of Medicine)
Oussama Abla
(The Hospital for Sick Children, Canada)
Ichiro Murakami
(Department of Pathology, Kochi University, Kochi, Japan)
Kensuke Miyake
(Div Innate Immunity, Tokyo Univ, Tokyo, Japan)

Ⓔ Symposium 3

Thursday, September 23 15:00-17:00 No.1

Front Line of Genomic Analysis in Chronic Myeloid Leukemia

Chair：

Naoto Takahashi
(Akita University Graduate School of Medicine)
Tomoiku Takaku
(Juntendo University School of Medicine)

Speaker：

Junichiro Yuda
(Department of Hematology and Experimental Therapeutics, National Cancer Center Hospital East)
Sin Tiong Ong
(Programme in Cancer & Stem Cell Biology, Duke-NUS Medical School, Singapore)
Simona Soverini
(Hematology/Oncology "L. e A. Seràgnoli", University of Bologna, Italy)
Susan Branford
(Centre for Cancer Biology, SA Pathology, Adelaide, SA, Australia)

Ⓔ Symposium 4

Thursday, September 23 15:00-17:00 No.2

Recent Advances in the Field of Bone Marrow Failure

Chair：

Hirohito Yamazaki
(Division of Transfusion Medicine, Kanazawa University Hospital)
Atsushi Manabe
(Department of Pediatrics, Hokkaido University Graduate School of Medicine)

Speaker：

Fumihiro Ishida
(Biomedical Laboratory Sci., Shinshu Univ., Matsumoto, Japan)
Antonio M. Risitano
(AORN San Giuseppe Moscati, Avellino, Italy)
Satu Mustjoki
(Hematology Research Unit Helsinki, Department of Hematology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland)
Kohei Hosokawa
(Kanazawa University Hospital, Ishikawa, Japan)
Hideki Muramatsu
(Department of Pediatrics, Nagoya University Graduate School of Medicine)

Ⓔ Symposium 5

Friday, September 24 9:00-11:00 No.1

Post CD19CAR-T Immune Cell Therapy

Chair：

Naoki Hosen
(Dept. of Hematology and Oncology, Osaka University Graduate School of Medicine)
Norimitsu Kadowaki
(Department of Internal Medicine, Division of Hematology, Rheumatology and Respiratory Medicine, Faculty of Medicine, Kagawa University)

Speaker：

Yozo Nakazawa
(Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan)
Ken Ohmine
(Div. of Hematol, Jichi Medical Univ., Tochigi, Japan)
Jan Joseph Melenhorst
(University of Pennsylvania, USA)
Naoto Hirano
(Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada)
Katy Rezvani
(Chief, Section of Cellular Therapy, Medical Director of GMP and Cellular Therapy
Laboratory, USA)

Ⓔ Symposium 6

Friday, September 24 9:00-11:00 No.2

A Better Understanding of GVHD Biology on the Basis of the Intestinal Immunity

Chair：

Koji Kato
(Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital)
Yoshihiro Inamoto
(National Cancer Center Hospital)

Speaker：

Robert Zeiser
(Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany)
Motoko Koyama
(Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA)
Jonathan Peled
(Memorial Sloan Kettering Cancer Center, USA)
Hideaki Fujiwara
(Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan)

Symposium 7

Friday, September 24 9:00-9:50 No.3

Current Status and Issues of Genomic Medicine in Hematology

Chair：

Daisuke Ennishi
(Center for Comprehensive Genomic Medicine)
Akifumi Takaori-Kondo
(Department of Hematology/Oncology, Graduate School of Medicine, Kyoto University)

Panelist:

Junya Kanda
(Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University)
Hideki Muramatsu
(Department of Pediatrics, Nagoya University Graduate School of Medicine)

Speaker：

Keisuke Kataoka
(Div. Hematol., Dept. Med., Keio Univ. Sch.Med., Tokyo, Japan)
Takahiro Maeda
(Division of Precision Medicine, Kyushu University Graduate School of Medical Sciences)
Yasuhito Nannya
(Hematol&Oncol IMSUT Tokyo Univ., Tokyo, Japan)

Ⓔ Symposium 8(JSH-EHA Joint Symposium)

Friday, September 24 15:00-17:00 No.2

New Phase of the Treatment of Intractable Lymphoma

Chair：

Kenichi Ishizawa
(Department of Third Internal Medicine, Yamagata University Faculty of Medicine)
Elizabeth Macintyre
(Hôpital Necker - Enfants Malades laboratoire oncohématologie, France)

Speaker：

Momoko Nishikori
(Dept Hematol/Oncol, Kyoto Univ., Kyoto, Japan)
Mamiko Sakata-Yanagimoto
(Hematol., Univ. Tsukuba., Ibaraki, Japan)
Andrés J. M. Ferrer
(Lymphoma Unit, Department of Onco-hematology, IRCCS San Raffaele
Scientific Institute, Milano, Italy)
Martin Dreyling
(Department of Medicine III, University Hospital LMU München, Germany)

Ⓔ Symposium 9(JSH-ASH Joint Symposium)

Saturday, September 25 9:00-11:00 No.1

Recent Advance in the Immunotherapy for Multiple Myeloma

Chair：

Junya Kuroda
(Division of Hematology and Oncology, Department of Medicine Kyoto
Prefectural University of Medicine)
Stephanie J. Lee
(Fred Hutchinson Cancer Research Center (FHCRC) and
University of Washington (UW), Seattle, WA, USA)

Speaker：

Takumi Ito
(Dept. Chem. Biol., Tokyo Med. Univ., Tokyo, Japan)
Hideki Goto
(Department of hematology, Hokkaido University Hospital)
Deepu Madduri
(Hematology/ Oncology - Multilple Myeloma, Mount Sinai Hospital, USA)
Suzanne Lentzsch
(Columbia University, School of Medicine/Hematology-Oncology, New York, NY, USA)

Ⓔ Symposium 10

Saturday, September 25 14:00-16:00 No.1

Recent Progress in Hematopoietic Regulation

Chair：

Yoshio Katayama
(Hematology, Kobe University Hospital)
Hitoshi Takizawa
(International Research Center for Medical Sciences, Kumamoto University)

Speaker：

Ralf H. Adams
(Max Planck Institute for Molecular Biomedicine, Department Tissue Morphogenesis, and University of Muenster, Faculty of Medicine, Muenster, Germany)
Keiyo Takubo
(National Center for Global Health and Medicine, Tokyo, Japan)
Takafumi Yokota
(Department of Hematology and Oncology, Osaka University, Suita, Osaka, Japan)
Masayuki Yamashita
(Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan)
Andreas Trumpp
(HI-STEM gGmbH, Heidelberg Institute for Stem Cell Technolgoy and Experimental
Medicine, in the German Cancer Research Center (DKFZ), Germany)

Ⓔ Symposium 11

Saturday, September 25 14:00-16:00 No.3

New Drug Modalities for the Treatment of Hemostatic and Thrombotic Disorders

Chair：

Katsue Suzuki-Inoue
(Department of Clinical and Laboratory Medicine, Faculty of Medicine, University of Yamanashi)
Tsukasa Ohmori
(Department of Biochemistry, Jichi Medical University)

Speaker：

Amit Nathwani
(Professor of Haematology Senior, National Institute for Health Research (NIHR)
Investigator and Head of Department of Haematology University College London Royal Free Campus, UK)
Osamu Nureki
(Department of Biological Science, Tokyo Univ., Tokyo, Japan)
Yumiko Matsubara
(Clinical and Translational Research Center, Keio Univ., Tokyo, Japan)
Masanori Matsumoto
(Department of Blood Transfusion Medicine, Nara Medical University, Kashihara, Japan)
Koichi Hattori
(Cntr. Genomic. Regen., Juntendo Univ. Sch. Med. Tokyo, Japan)

Women Doctors Career SymposiumLive Recording On-demand

Friday, September 24 9:30-11:00No.11

Possibilities of Diverse Careers for Women Doctors

Chair：

Itaru Matsumura
(Depertment of Hematology and Rheumatology, Kindai University Faculty of Medicine)
Motoko Yamaguchi
(Department of Hematological Malignancies, Mie University Graduate School of Medicine)

Speaker：

Tomoko Narita
(Department of Hematology & Oncology, Nagoya City University
Graduate School of Medical Sciences)
Akiko Saito
(National Hospital Organization Nagoya Medical Center)
Tokiko Nagamura-Inoue
(Research hospital, Institute of Med. Science, UTokyo, Tokyo, Japan)

<On-demand Distribution>

Educational Lecture

Educational Lecture 1

Molecular mechanisms of myeloid malignancies

Speaker：

Hirotaka Matsui
(Department of Molecular Laboratory Medicine, Kumamoto University, Kumamoto, Japan)

Educational Lecture 2

Clonal hematopoiesis

Speaker：

Toshio Kitamura
(Advanced Clinical Research Center, The Institute of Medical Science, The
University of Tokyo, Tokyo, Japan)

Educational Lecture 3

Gut microbiota, immunity, and autoimmune diseases

Speaker：

Hiroshi Ohno
(Laboratory for Intestinal Ecosystem, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan)

Educational Lecture 4

Trace metals and anemia

Speaker：

Akiyoshi Takami
(Department of Internal Medicine, Division of Hematology, Aichi Medical University
School of Medicine, Aichi, Japan)

Educational Lecture 5

Thalassemia in Japan

Speaker：

Hideho Wada
(Department of Hematology, Kawasaki Medical School, Kurashiki, Japan)

Educational Lecture 6

Diagnosis and treatment for aplastic anemia

Speaker：

Kensuke Usuki
(Department of Hematology, Medical Center Tokyo, Tokyo, Japan)

Educational Lecture 7

Diagnosis and management of pure red cell aplasia

Speaker：

Naohito Fujishima
(Division of Blood Transfusion, Akita University Hospital, Akita, Japan)

Educational Lecture 8

Future perspectives of treatment for anemia in chronic kidney disease (CKD) using hypoxia-inducible factor prolyl hydroxylase inhibitors

Speaker：

Masaomi Nangaku
(Division of Nephrology and Endocrinology, The University of Tokyo Graduate
School of Medicine, Bunkyo-ku, Tokyo, Japan)

Educational Lecture 9

Advances in research for pathogenesis of paroxysmal nocturnal hemoglobinuria

Speaker：

Yoshiko Murakami
(Research Institute for Microbial Diseases, Osaka University, Osaka, Japan)

Educational Lecture 10

FLT3 inhibitors in the treatment of FLT3-mutated acute myeloid leukemia

Speaker：

Naomi Kawashima
(Department of Hematology and Oncology, Nagoya University Graduate School of
Medicine, Nagoya, Japan)

Educational Lecture 11

Stratified treatment of fit and unfit acute myeloid leukemia

Speaker：

Goichi Yoshimoto
(Department of Hematology, Saga-Ken Medical Centre Koseikan, Saga, Japan)

Educational Lecture 12

Maintenance therapy for acute myeloid leukemia (including in patients who have undergone transplantation) including off-label use drugs in Japan

Speaker：

Toru Kiguchi
(Dokkyo Medical University, Saitama Medical Center, Department of Diabetes,
Endocrinology and Hematology, Saitama, Japan)

Educational Lecture 13

The mechanism of MLL-rearranged leukemogenesis and its targeted therapies

Speaker：

Akihiko Yokoyama
(National Cancer Center Tsuruoka Metabolomics Laboratory)

Educational Lecture 14

The coronavirus disease 2019 (COVID-19) and hematologic oncology or BMT practice at our center in US

Speaker：

Shin Mineishi
(Penn State Hershey Medical Center, Blood and Marrow Transplant Program, PA, United States)

Educational Lecture 15

Genomics-based precision medicine in hematology/oncology

Speaker：

Takahiro Maeda
(Division of Precision Medicine, Kyushu University School of Medicine, Fukuoka, Japan)

Educational Lecture 16

What is the best treatment for chronic-phase CML?

Speaker：

Emiko Sakaida
(Department of Hematology and Stem Cell Transplant Center,
Chiba University Hospital, Chiba, Japan)

Educational Lecture 17

Tyrosine kinase inhibitor-associated cardiovascular adverse events in chronic myeloid leukemia

Speaker：

Sakiko Miyazaki
(Department of Cardiovascular Biology and Medicine, Juntendo University Graduate
School of Medicine, Tokyo, Japan)

Educational Lecture 18

Genetic predisposition to myelodysplastic syndrome/leukemia

Speaker：

Shinsuke Hirabayashi
(Department of Pediatrics, Hokkaido University Hospital, Hokkaido, Japan)

Educational Lecture 19

Treatment for myelodysplastic syndromes and future perspectives in the genomic era

Speaker：

Tomoya Maeda
(Department of Hemato-Oncology, Saitama International Medical Center, Saitama
Medical University, Saitama, Japan)

Educational Lecture 20

State-of-the-art management for essential thrombocythemia and polycythemia vera

Speaker：

Yuka Sugimoto
(Department of Community Hematology, Mie University Faculty of Medicine, Mie, Japan)

Educational Lecture 21

Clinical impact of gene mutations on myeloproliferative neoplasms in Japan

Speaker：

Soji Morishita
(Laboratory for the Development of Therapies against MPN, Juntendo University
Graduate School of Medicine, Tokyo, Japan)

Educational Lecture 22

The current therapeutic landscape for follicular lymphoma

Speaker：

Tsutomu Kobayashi
(Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan)

Educational Lecture 23

Current status of diagnosis and treatment in diffuse large B-cell lymphoma

Speaker：

Kazuyuki Shimada
(Department of Hematology and Oncology, Nagoya University Graduate School of
Medicine, Aichi, Japan)

Educational Lecture 24

Molecular pathogenesis and treatment of chronic lymphocytic leukemia

Speaker：

Ritsuro Suzuki
(Department of Hematology and Oncology, Shimane University School of Medicine,
Shimane, Japan)

Educational Lecture 25

B cell acute lymphoblastic leukemia therapy: an up to date overview

Speaker：

Fumihiko Hayakawa
(Division of Cellular and Genetic Sciences, Nagoya University Graduate School
of Medicine, Aichi, Japan)

Educational Lecture 26

Initial treatment strategy for classical Hodgkin lymphoma in adults

Speaker：

Shigeru Kusumoto
(Department of Hematology and Oncology, Nagoya City University Graduate
School of Medical Sciences, Aichi, Japan)

Educational Lecture 27

Current treatment strategies for peripheral T-cell lymphoma

Speaker：

Wataru Munakata
(Department of Hematology, National Cancer Center Hospital, Tokyo, Japan)

Educational Lecture 28

Genetic studies on lymphoma

Speaker：

Keisuke Kataoka
(Division of Hematology, Department of Medicine, Keio University School of
Medicine, Tokyo, Japan)

Educational Lecture 29

Assessment of the leukemogenic mechanism of Ph-like acute lymphocytic leukemia for the identification of a novel therapeutic target

Speaker：

Toshihiko Imamura
(Department of Pediatrics, Kyoto Prefectural University of Medicine,
Graduate School of Medical Science, Kyoto, Japan)

Educational Lecture 30

Therapeutic algorithm of Waldenströmʼs macroglobulinemia or lymphoplasmacytic lymphoma in Japan

Speaker：

Naohiro Sekiguchi
(Department of Hematology, National Hospital Organization Disaster Medical Center, Tokyo, Japan)

Educational Lecture 31

Treatment strategies for longer life of patients with transplant-ineligible multiple myeloma

Speaker：

Noriko Nishimura
(Division of Hematology/Oncology, Cancer Institute Hospital of
Japanese Foundation for Cancer Research)

Educational Lecture 32

Treatment strategy for immunoglobulin light chain amyloidosis

Speaker：

Shin-ichi Fuchida
(JCHO Kyoto Kuramaguchi Medical Center, Kyoto, Japan)

Educational Lecture 33

Antibody therapy for multiple myeloma

Speaker：

Hiroshi Handa
(Department of Hematology, Gunma University Graduate School of Medicine, Gunma, Japan)

Educational Lecture 34

Practical guidance for the management of patients with hematological disorders during the coronavirus disease 2019 pandemic in Japan

Speaker：

Masao Hagihara
(Eiju General Hospital, Tokyo, Japan)

Educational Lecture 35

The immune microenvironment of multiple myeloma

Speaker：

Kyohei Nakamura
(QIMR Berghofer Medical Research Institute, Australia)

Educational Lecture 36

Approaches to hemostatic testing consultations encountered by hematologists

Speaker：

Takayuki Ikezoe
(Department of Hematology, Fukushima Medical University, Fukushima, Japan)

Educational Lecture 37

The diagnosis and management of von Willebrand disease

Speaker：

Tadashi Matsushita
(Department of Transfusion Medicine, Nagoya University Hospital, Aichi, Japan)

Educational Lecture 38

Current developments in hemostatic treatment for patients with hemophilia

Speaker：

Keiji Nogami
(Department of Pediatrics, Nara Medical University, Nara, Japan)

Educational Lecture 39

Treatment strategy for patients with thrombotic thrombocytopenic purpura

Speaker：

Hideo Yagi
(The Department of Hematology and Oncology, Nara Prefecture General Medical Center, Nara, Japan)

Educational Lecture 40

Treatment of ITP

Speaker：

Kenji Yokoyama
(Department of Hematology/Oncology, Tokai University Hachioji Hospital, Tokyo, Japan)

Educational Lecture 41

COVID-19-associated coagulopathy

Speaker：

Eriko Morishita
(Department of Laboratory Science, School of Health Sciences, College of Medical,
Pharmaceutical and Health Sciences, Kanazawa University, Ishikawa, Japan)

Educational Lecture 42

Practical blood transfusion and adverse transfusion reactions

Speaker：

Ryuji Tanosaki
(Center for Transfusion Medicine and Cell Therapy,
Keio University School of Medicine, Tokyo, Japan)

Educational Lecture 43

Diagnosis and treatment of sinusoidal obstruction syndrome (veno-occlusive disease)

Speaker：

Atsushi Kikuta
(Department of Pediatric Oncology, Fukushima Medical University, Fukushima, Japan)

Educational Lecture 44

Antithymocyte globulin for GVHD prophylaxis in allogeneic hematopoietic stem cell transplantation

Speaker：

Souichi Shiratori
(Department of Hematology, Hokkaido University Faculty of Medicine, Hokkaido, Japan)

Educational Lecture 45

Future perspective of allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia

Speaker：

Motohiro Kato
(Department of Pediatrics, the University of Tokyo, Tokyo, Japan)

Educational Lecture 46

Graft-versus-host disease: current understanding of immune pathogenesis and clinical treatment

Speaker：

Ken-ichi Matsuoka
(Department of Hematology, Oncology and Respiratory medicine, Okayama
University, Academic Field of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan)

Educational Lecture 47

Respiratory virus infections after hematopoietic cell transplantation

Speaker：

Sachiko Seo
(Dokkyo Medical University, Tochigi, Japan)

Educational Lecture 48

Emerging infectious disease and transfusion-transmitted infection

Speaker：

Yuji Yonemura
(Kumamoto Red Cross Blood Center, Kumamoto, Japan)

Educational Lecture 49

Interleukin-34: a key molecule in the tumor microenvironment

Speaker：

Ken-ichiro Seino
(Division of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Hokkaido, Japan)

Educational Lecture 50

Acute leukemia of infants and neonates

Speaker：

Mariko Eguchi
(Department of Pediatrics, Ehime University Graduate School of Medicine, Toon, Japan)

Educational Lecture 51

Congenital thrombocytopenia

Speaker：

Yoji Sasahara
(Department of Pediatrics, Tohoku University Graduate School of Medicine, Miyagi, Japan)

Educational Lecture 52

Treating inherited bone marrow failure syndromes and primary immunodeficiency diseases

Speaker：

Masataka Ishimura
(Department of Pediatrics, Graduate School of Medical Sciences,
Kyushu University, Fukuoka, Japan)

Educational Lecture 53

Viral infections after hematopoietic cell transplantation and treatment with virus-specific T-cell therapies

Speaker：

Takahiro Kamiya
(Department of Pediatrics, Tokyo Medical and Dental University Medical hospital, Tokyo, Japan)

Educational Lecture 54

Medical ethics and research ethics

Speaker：

Tadao Takano
(Clinical Research, Innovation and Education Center, Tohoku University Hospital(CRIETO), Tokyo, Japan)

Educational Lecture 55

Management of conflict of interest in Japanese Society of Hematology

Speaker：

Hideaki Nakajima
(Department of Stem Cell and Immune Regulation,
Yokohama City University Graduate School of Medicine, Kanagawa, Japan)

<Live Streaming Distribution>

Corporate Seminar

Morning Seminar2-2

Friday, September 24 7:55-8:40No.2

Sponsor: Janssen Pharmaceutical K.K. , Medical Affairs Division

Chair:

Nagaaki Kato
(Department of Medicine rology and Rheumatology), Shinshu University School of Medicine)

The role of cardiologist in the diagnosis and treatment of AL cardiac amyloidosis

Speaker:

Jin Endo
(Department of Cardiology, Keio University School of Medicine)

Fundamentals of AL amyloidosis for hematologists

Speaker:

Nobuhiro Tsukada
(Department of Hematology, Japanese Red Cross Medical Center)

Morning Seminar2-3

Friday, September 24 7:55-8:40No.3

Remarkable evolution of therapeutic strategy for Ph-positive ALL

Sponsor: Otsuka Pharmaceutical Co., Ltd.

Chair:

Chiaki Nakaseko
(Department of Hematology, International University of Health and Welfare School of Medicine)

Speaker:

Hirohisa Nakamae
(Hematology, Graduate School of Medicine, Osaka City University.)

Morning Seminar2-4 Live Recording On-demand

Friday, September 24 7:55-8:40No.4

Current CML treatment and CVE management

Sponsor: Novartis Pharma K.K.

Chair:

Arinobu Tojo
(Tokyo Medical and Dental University)

CVE management during TKI treatment

Speaker:

Tomoiku Takaku
(Department of Hematology, Juntendo University School of Medicine)

Introduction to Onco-cardiology

Speaker:

Sakiko Miyazaki
(Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine)

Ⓔ Morning Seminar2-5

Friday, September 24 7:55-8:40No.5

Epigenetic Basis of Follicular Lymphoma

Sponsor: Eisai Co.,Ltd.

Chair:

Daisuke Ennishi
(Department of Hematology and Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences)

Speaker:

Michael R. Green
(Department of Lymphoma-Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center)

Morning Seminar2-6

Friday, September 24 7:55-8:40No.6

Effective autologous stem cell mobilization ~Clinical experiences of Mozobil~

Sponsor: Sanofi K.K.

Chair:

Dai Maruyama
(Department of Hematology Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research)

Speaker:

Junya Kanda
(Department of Hematology/Oncology , Graduate school of Medicine, Kyoto University)
Masataka Takeshita
(Department of Hematology, Tokyo-Kita Medical Center)

Ⓔ Morning Seminar2-7

Friday, September 24 7:55-8:40No.7

Treatment of relapsed and refractory follicular lymphoma

Sponsor: Bristol-Myers Squibb K.K.

Chair:

Kiyoshi Ando
(Department of Hematology/Oncology, Tokai University School of Medicine, Japan)

Speaker:

John Gribben
(Chair of Medical Oncology Barts Cancer Institute Queen Mary, University of London, UK)

Morning Seminar2-8

Friday, September 24 7:55-8:40No.8

Clinical Significance of Minimal Residual Disease (MRD) Detection in Hematologic Malignancy

Sponsor: Amgen K.K. Medical Affairs / Astellas Pharma Inc.

Chair:

Masashi Sanada
(National Hospital Organization Nagoya Medical Center)

Speaker:

Hiroyuki Takamatsu
(Kanazawa University)

Morning Seminar2-9 Live Recording On-demand

Friday, September 24 7:55-8:40No.9

Autoimmune Hemolytic Anemia: Advances in Diagnosis, Classification and Pathophysiology

Sponsor: Sanofi K.K.

Chair:

Hideho Wada
(Department of Hematology, Kawasaki Medical School )

Speaker:

Yasutaka Ueda
(Department of Hematology and Oncology, Graduate School of Medicine, Osaka University)

Morning Seminar2-10

Friday, September 24 7:55-8:40No.10

Current advances and ongoing issues of hemophilia treatment, and personalized care as a solution - in the light of the appropriate use of Afstyla -

Sponsor: CSL Behring K.K.

Chair:

Satoshi Higasa
(Department of Respiratory Medicine and Hematology, Hyogo College of Medicine)

Speaker:

Kagehiro Amano
(Tokyo Medical University. Department of Laboratory Medicine)

Morning Seminar2-11

Friday, September 24 7:55-8:40No.11

Therapeutic strategy for classical Hodgkin lymphoma

Sponsor: ONOPHARMACEUTICALCO.,LTD. / Bristol-Myers Squibb K.K.

Chair:

Akihiro Tomita
(Fujita Health University School of Medicine Hematology)

Speaker:

Toshiro Kawakita
(National Hospital Organization Kumamoto Medical Center)

Morning Seminar2-12

Friday, September 24 7:55-8:40No.12

Appropriate timing for CAR-T therapy in relapsed refractory DLBCL

Sponsor: DAIICHI SANKYO COMPANY, LIMITED

Chair:

Nobuharu Fujii
(Division of Transfusion, Okayama University Hospital)

Speaker:

Hideki Goto
(Department of Hematology, Hokkaido University Hospital)

Morning Seminar2-13A

Friday, September 24 7:55-8:40No.13A

Risk management and treatment for sinusoidal obstruction syndrome

Sponsor: Nippon Shinyaku Co., Ltd.

Chair:

Takayuki Ikezoe
(Department of Hematology, School of Medicine, Fukushima Medical University)

Speaker:

Ken-ichi Matsuoka
(Department of Hematology, Oncology and Respiratory medicine, Academic Field of Medicine, Dentistry and Pharmaceutical Sciences, Academic Research Assembly, Okayama University)

Morning Seminar3-1

Saturday, September 25 7:55-8:40No.1

Evolution of Treatment driven by Anti-CD38 Antibodies

Sponsor: Janssen Pharmaceutical K.K

Chair:

Emiko Sakaida
(Department of Hematology Chiba University Hospital)

Current Diagnosis and Therapy

Speaker:

Kenshi Suzuki
(Japanese Red Cross Medical Center , Myeloma･AL amyloid unit)

Morning Seminar3-2

Saturday, September 25 7:55-8:40No.2

Current trends in immunology for hematology

Sponsor: MSD K.K.

Chair:

Takahiro Fukuda
(National Cancer Center Hospital, Department of Hematopoietic Stem Cell Transplantation)

Current trends in cancer immunotherapy

Speaker:

Shigehisa Kitano
(JAPANESE FOUNDATION FOR CANCER RESEARCH, The Cancer Institute Hospital, Advanced Medical Development Center, Division of Cancer Immunotherapy Development)

Managing infections in hematological malignancies

Speaker:

Toshihiro Miyamoto
(Department of Hematology, Faculty of Medicine, Institute of Medical Pharmaceutical and Health Sciences, Kanazawa University)

Ⓔ Morning Seminar3-3

Saturday, September 25 7:55-8:40No.3

Clinical management of and resistance to venetoclax in AML

Sponsor: AbbVie GK

Chair:

Koichi Akashi
(Kyushu University, Graduate School of Medical Sciences)

Speaker:

Daniel A. Pollyea
(University of Colorado, Department of Medicine, Division of Hematology, USA)

Morning Seminar3-4

Saturday, September 25 7:55-8:40No.4

Treatment strategy with brentuximab vedotin for primary CD30 positive T cell lymphoma

Sponsor: Takeda Pharmaceutical Company Limited

Chair:

Kenichi Ishizawa
(Department of Third Internal Medicine Division of Hematology and Cell Therapy,Yamagata University Faculty of Medicine)

Speaker:

Hirohiko Shibayama
(Department of Hematology,National Hospital Organization Osaka National Hospital)

Morning Seminar3-5

Saturday, September 25 7:55-8:40No.5

Points of treatment selection for ITP and AA under COVID-19

Sponsor: Kyowa Kirin Co., Ltd.

Chair:

Shigeru Chiba
(Department of Hematology , University of Tsukuba Hospital)

Diagnosis and treatment of ITP

Speaker:

Hirokazu Kashiwagi
(Department of Hematology and Oncology, Graduate School of Medicine, Osaka University)

Impact of TPO-RA in the treatment of aplastic anemia

Speaker:

Hirohito Yamazaki
(Division of Transfusion Medicine, Kanazawa University Hospital)

Morning Seminar3-6 Live Recording On-demand

Saturday, September 25 7:55-8:40No.6

Clinical practice update on Kymriah therapy in Japan

Sponsor: Novartis Pharma K.K.

Chair:

Yasushi Onishi
(Department of Hematology,Tohoku University Hospital)

Speaker:

Toshio Kitawaki
(Department of Hematology and Oncology, Kyoto University Hospital)

Morning Seminar3-7

Saturday, September 25 7:55-8:40No.7

Antifungal Treatment in Hematological Patients in the era of various options for antifungal prophylaxis

Sponsor: Pfizer Japan Inc.

Chair:

Yoshinobu Kanda
(Division of Hematology, Jichi Medical University)

Speaker:

Shun-ichi Kimura
(Division of Hematology, Jichi Medical University Saitama Medical Center)

Morning Seminar3-8

Saturday, September 25 7:55-8:40No.8

Total therapeutic strategies for the treatment of follicular lymphoma

Sponsor: CHUGAI PHARMACEUTICAL CO., LTD./Nippon Shinyaku Co., Ltd.

Chair:

Naoki Hosen
(Department of Hematology and Oncology, Osaka University Graduate School of Medicine)

Speaker:

Kazuyuki Shimada
(Department of Hematology, Nagoya University Hospital)

Morning Seminar3-9 Live Recording On-demand

Saturday, September 25 7:55-8:40No.9

Quantitative evaluation of MRD in Ph(+) ALL-Using minor BCR-ABL1

Sponsor: Otsuka Pharmaceutical Co., Ltd.

Chair:

Yuzuru Kanakura
(Sumitomo Hospital)

Speaker:

Koiti Inokuchi
(Nippon Medical School)

Morning Seminar3-10

Saturday, September 25 7:55-8:40No.10

Progress in Treatment of Chronic Myeloid Leukemia

Sponsor: Bristol-Myers Squibb K.K.

Chair:

Akifumi Takaori-Kondo
(Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University)

Speaker:

Nobuhiko Uoshima
(Department of Hematology,Japanese Red Cross,Kyoto Daini Hospital)

Morning Seminar3-11

Saturday, September 25 7:55-8:40No.11

Update on Hemophilia management in 2021

Sponsor: Sanofi K.K.

Chair:

Tadashi Matsushita
(Department of Transfusion Medicine, Nagoya University Hospital)

Speaker:

Azusa Nagao
(Department of Blood Coagulation, Ogikubo Hospital )

Morning Seminar3-12

Saturday, September 25 7:55-8:40No.12

The first step for diagnosis and treatment of acquired hemophilia A

Sponsor: Takeda Pharmaceutical Company Limited

Chair:

Kazunori Imada
(Department of Hematology, Japanese Red Cross Osaka Hospital)

Speaker:

Masato Bingo
(Department of Laboratory Medicine, Tokyo Medical University)

Morning Seminar3-13

Saturday, September 25 7:55-8:40No.13

Genomic analysis of ATL/PTCL pathogenesis and its clinical application

Sponsor: Meiji Seika Pharma Co.,Ltd.

Chair:

Kunihiro Tsukasaki
(Department of Hematology, International Medical Center, Saitama Medical University)

Speaker:

Keisuke Kataoka
(Division of Hematology Department of Medicine Keio University School of Medicine)

Luncheon Seminar1-1

Thursday, September 23 12:15-13:00No.1

RRMM treatment strategy using IsaPd therapy based on basic and clinical

Sponsor: Sanofi K.K.

Chair:

Tadao Ishida
(Department of Hematology, Department of Myeloma-Amyloidosis center, Japanese Red Cross Medical Center, Tokyo, Japan)

Speaker:

Yusuke Furukawa
(Division of Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical University)
Takashi Ikeda(Division of Hematology and Stem Cell Transplantation, Shizuoka Cancer Center, Shizuoka, Japan.)

Ⓔ Luncheon Seminar1-2

Thursday, September 23 12:15-13:00No.2

Therapeutic strategy for Relapsed and Refractory Multiple Myeloma

Sponsor: ONOPHARMACEUTICALCO.,LTD.

Chair:

Shinsuke Iida
(Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences)

Speaker:

Hirokazu Tanaka
(Department of Hematology and Rheumatology, Kindai University Faculty of Medicine)
Saad Z. Usmani
(Department of Hematologic Oncology & Blood Disorders, Levine Center Institute)

Ⓔ Luncheon Seminar1-3

Thursday, September 23 12:15-13:00No.3

Latest updates in the CLL treatment

Sponsor: AstraZeneca K.K.

Chair:

Yasushi Takamatsu
(Division of Medical Oncology, Hematology and Infectious Diseases, Department of Internal Medicine, Fukuoka University)

Speaker:

Paolo Ghia
(Vita-Salute San Raffaele University)

Luncheon Seminar1-4

Thursday, September 23 12:15-13:00No.4

Recent advances in the treatment of DLBCL

Sponsor: Chugai Pharmaceutical Co., Ltd.

Chair:

Motoko Yamaguchi
(Department of Hematological Malignancies, Mie University Graduate School of Medicine)

Speaker:

Koji Kato
(Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital)

Luncheon Seminar1-5

Thursday, September 23 12:15-13:00No.5

The pathogenesis and biology of GVHD

Sponsor: Janssen Pharmaceutical K.K. , Medical Affairs Division

Chair:

Daigo Hashimoto
(Department of Hematology, Hokkaido University Faculty of Medicine)

Speaker:

Motoko Koyama
(Hill Lab, Clinical Research Division, Fred Hutchinson Cancer Research Center)

Luncheon Seminar1-6 Live Recording On-demand

Thursday, September 23 12:15-13:00No.6

Therapeutic strategies for myelofibrosis to improve prognosis and thrombotic risk and management in polycythemia vera

Sponsor: Novartis Pharma K.K.

Chair:

Shuichi Ota
(Department of Hematology, Sapporo Hokuyu Hospital)

Speaker:

Yoshinori Hashimoto
(Department of Hematology, Juntendo University School of Medicine)

Luncheon Seminar1-7

Thursday, September 23 12:15-13:00No.7

Idiopathic Thrombocytopenic Purpura: Up to Date on Diagnosis and Treatment

Sponsor: Sysmex Corporation

Chair:

Tohru Fujiwara
(Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine/Laboratory Diagnostics, Tohoku University Hospital)

Speaker:

Yoshiaki Tomiyama
(Department of Internal Medicine, Uegahara Hospital )

Luncheon Seminar1-8

Thursday, September 23 12:15-13:00No.8

Current treatment of ATL and future direction

Sponsor: Meiji Seika Pharma Co.,Ltd.

Chair:

Masao Matsuoka
(Department of Hematology and Rheumatology and Infectious Disease Medicine, Kumamoto University)

Speaker:

Atae Utsunomiya
(Department of Hematology, Imamura General Hospital)

Luncheon Seminar1-9

Thursday, September 23 12:15-13:00No.9

Growing presence of Gilteritinib in the treatment of acute myeloid leukemia harboring FLT3 mutations.

Sponsor: Astellas Pharma Inc.

Chair:

Hiroki Yamaguchi
(Department of Hematology, Nippon Medical School)

Speaker:

Takeshi Kondo
(Blood Disorders Center, Aiiku Hospital)

Luncheon Seminar1-10

Thursday, September 23 12:15-13:00No.10

The role of chemotherapy in the treatment of Diffuse Large B-cell Lymphoma in the Era of CAR-T cell therapy

Sponsor: Kyowa Kirin Co., Ltd.

Chair:

Yasuhito Terui
(Department of Hematology, Saitama Medical University.)

Speaker:

Tatsu Shimoyama
(Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan)

Luncheon Seminar1-11

Thursday, September 23 12:15-13:00No.11

Cutting edge of precision medicine and FLT3 targeted therapy in AML

Sponsor: DAIICHI SANKYO COMPANY, LIMITED

Chair:

Takayuki Ishikawa
(Kobe City Medical Center General Hospital Department of Hematology )

Speaker:

Yosuke Minami
(Department of Hematology, National Cancer Center Hospital East)

Luncheon Seminar1-12

Thursday, September 23 12:15-13:00No.12

2021 CML update on therapy and monitoring

Sponsor: Otsuka Pharmaceutical Co., Ltd.

Chair:

Naoto Takahashi
(Akita University Graduate School of Medicine and Faculty of Medicine Department of Hematology, Nephrogy, and Rheumatology)

Speaker:

Koji Sasaki
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, USA)

Luncheon Seminar1-13A

Thursday, September 23 12:15-13:00No.13A

Appropriate use of antimicrobials in patients with blood disorders

Sponsor: Shionogi & Co., LTD

Chair:

Yoshihiro Hatta
(Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine)

Speaker:

Nobuyuki Shimono
(Department of General Internal Medicine, Kyushu University Hospital)

Luncheon Seminar1-13B Live Recording On-demand

Thursday, September 23 12:15-13:00No.13B

Sponsor: Bayer Yakuhin, Ltd.

Chair:

Teruhisa Fujii
(Head of Division of Transfusion Medicine, AIDS care Unit & Hemophilia Treatment Center, Hiroshima University Hospital)
Hideyuki Takedani
(IMSUT Hospital, Department of Joint Surgery)

Hemophilic arthropathic issues based on the nationwide 2020 survey on QOL of persons with hemophilia

Speaker:

Hideyuki Takedani
(IMSUT Hospital, Department of Joint Surgery)

What we can do to control hemoarthrosis and prevent the progression of arthropathy.

Speaker:

Teruhisa Fujii
(Head of Division of Transfusion Medicine, AIDS care Unit & Hemophilia Treatment Center, Hiroshima University Hospital)

Luncheon Seminar2-1

Friday, September 24 12:15-13:00No.1

Significance of maintenance therapy with proteasome inhibitors for multiple myeloma

Sponsor: Takeda Pharmaceutical Company Limited

Chair:

Masahiro Abe
(Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School)

Speaker:

Naoki Takezako
(Department of Hematology, Nerima Hikarigaoka Hospital)

Luncheon Seminar2-2

Friday, September 24 12:15-13:00No.2

Treatment strategies for Newly Diagnosed Multiple Myeloma based on the latest evidence

Sponsor: Bristol-Myers Squibb K.K.

Chair:

Chihiro Shimazaki
(Japan Community Health care Organization Kyoto Kuramaguchi Medical Center)

Speaker:

Hiroyuki Takamatsu
(Kanazawa University )

Luncheon Seminar2-3

Friday, September 24 12:15-13:00No.3

The role of Thiotepa in autologous hematopoietic stem cell transplantation for malignant lymphoma - experiences in Kansai Electric Power Hospital -

Sponsor: Sumitomo Dainippon Pharma Co., Ltd.

Chair:

Eisei Kondo
(Department of Hematology, Kawasaki Medical School)

Speaker:

Katsuhiro Io
(Department of Hematology, Kansai Electric Power Hospital)

Ⓔ Luncheon Seminar2-4

Friday, September 24 12:15-13:00No.4

First line treatment of CML in 2021: efficacy and safety profile of Bosutinib

Sponsor: Pfizer Japan Inc.

Chair:

Shinya Kimura
(Division of Hematology, Respiratory Medicine and Oncology, Saga University Hospital)

Speaker:

Tim H. Brümmendorf
(Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany)

Luncheon Seminar2-5

Friday, September 24 12:15-13:00No.5

Considerations of treatment for elderly AML in clinical practice

Sponsor: AbbVie GK

Chair:

Takahiro Yamauchi
(Department of Hematology and Oncology, University of Fukui)

Speaker:

Jun Ando
(Department of Hematology, Juntendo University School of Medicine)

Luncheon Seminar2-6 Live Recording On-demand

Friday, September 24 12:15-13:00No.6

Latest updates on the molecular pathophysiology of the myeloproliferative neoplasms

Sponsor: PharmaEssentia Japan KK

Chair:

Kazuhiko Ikeda
(Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University )

Speaker:

Kazuya Shimoda
(Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki)

Luncheon Seminar2-7

Friday, September 24 12:15-13:00No.7

Re-thinking the treatment of iron deficiency anemia

Sponsor: ZERIA Pharmaceutical Co,Ltd.

Chair:

Minami Fujiwara
(Division of Blood Transfusion and Cell Therapy,Tohoku University Hospital)

Speaker:

Tsutomu Sato
(Department of Hematology, Faculty of Medicine, University of Toyama)

Luncheon Seminar2-8

Friday, September 24 12:15-13:00No.8

Up to date on infectious disease management in patients with hematopoietic tumors

Sponsor: MSD K.K.

Chair:

Shuichi Taniguchi
(Hematology, Toranomon Hospital, Tokyo.)

New Strategy for CMV Prevention- Reconsidering CMV Monitoring

Speaker:

Katsuto Takenaka
(Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine)

Fungal infection control in hematologic malignancy - the role of Posaconazole

Speaker:

Hiromichi Iwasaki
(Department of Infection Control and Prevention, University of Fukui)

Luncheon Seminar2-9

Friday, September 24 12:15-13:00No.9

Advances in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma

Sponsor: SymBio Pharmaceucials Limited

Chair:

Tsutomu Kobayashi
(Division of Hematology and Oncology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine)

Speaker:

Kana Miyazaki
(Department of Hematology and Oncology, Mie University Graduate School of Medicine)

Luncheon Seminar2-10

Friday, September 24 12:15-13:00No.10

Update on treatment strategy for CLL

Sponsor: Zenyaku Kogyo Co., Ltd.

Chair:

Sadao Aoki
(Department of Pathophysiology, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences)

Update on treatment strategy for CLL 2021

Speaker:

Suguru Fukuhara
(Department of Hematology, National Cancer Center Hospital)

Luncheon Seminar2-11

Friday, September 24 12:15-13:00No.11

The Rare Disease Hiding in daily clinical practice - Relation of BMF and PNH -

Sponsor: Alexion Pharma GK

Chair:

Itaru Matsumura
(Department of Hematology and Rheumatology, Kindai University, Faculty of Medicine)

Speaker:

Akihiko Goto
(Department of Hematology, Tokyo Medical University)

Luncheon Seminar2-12

Friday, September 24 12:15-13:00No.12

The role and expectations of the new human cell-line derived recombinant factor VIII product in the treatment of hemophilia A - based on the data of Nuwiq

Sponsor: Fujimoto Pharmaceutical Group, Fujimoto Pharmaceutical Corporation.

Chair:

Midori Shima
(Thrombosis and Hemostasis Research Center, Nara Medical University)

Speaker:

Keiji Nogami
(Department of Pediatrics, Nara Medical University)

Luncheon Seminar2-13A

Friday, September 24 12:15-13:00No.13A

Precision Medicine in Hematogy/Oncology

Sponsor: Invivoscribe/LabPMM

Chair:

Hitoshi Kiyoi
(Department of Hematology and Oncology, Nagoya University Graduate School of Medicine)

Speaker:

Takahiro Maeda
(Division of Precision Medicine, Kyushu University Graduate School of Medical Sciences)

Luncheon Seminar2-13B

Friday, September 24 12:15-13:00No.13B

Understanding the Sepsis Guidelines

Sponsor: Asahi Kasei Pharma Corporation

Chair:

Yoshinobu Seki
(Department of Hematology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital.)

The management of DIC in Japanese Sepsis Guidelines 2020

Speaker:

Yutaka Umemura
(Division of Trauma and Surgical Critical Care, Osaka General Medical Center)

Luncheon Seminar3-1

Saturday, September 25 12:00-12:45No.1

Current Situation and Issues in Managing Graft-Versus-Host Disease

Sponsor: Novartis Pharma K.K.

Chair:

Takanori Teshima
(Department of Hematology, Hokkaido University Faculty of Medicine)

Speaker:

Yoshinobu Maeda
(Department of Hematology and Oncology, Okayama University Hospital)

Luncheon Seminar3-2

Saturday, September 25 12:00-12:45No.2

Treatment strategy for relapsed/refractory PTCL

Sponsor: Eisai Co.,Ltd.

Chair:

Shigeru Kusumoto
(Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences)

Speaker:

Shigeo Fuji
(Department of Hematology, Osaka International Cancer Institute)

Luncheon Seminar3-3

Saturday, September 25 12:00-12:45No.3

What has IsaPd changed treatment strategy of Double Refractory MM?

Sponsor: Sanofi K.K.

Chair:

Kazutaka Sunami
(Department of Hematology, National Hospital Organization Okayama Medical Center, Okayama, Japan)

Speaker:

Keichiro Mihara
(International Regenerative Medical Center, Fujita Health University, Aichi, Japan)
Kazuhito Suzuki
(Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University Kashiwa Hospital, Chiba, Japan.)

Luncheon Seminar3-4

Saturday, September 25 12:00-12:45No.4

New Findings of Multiple Myeloma - Clinical from the Basic Research -

Sponsor: Janssen Pharmaceutical K.K

Chair:

Shigeki Ito
(Division of Hematology and Oncology, Department of Internal Medicine, Iwate Medical University School of Medicine)

Significance of continuous DRd therapy considering CD38 expression status and mode of action

Speaker:

Akihiro Kitadate
(Department of Hematology, Nephrology,and Rheumatology, Akita University Graduate School of Medicine)

Subcutaneous CD38 Antibody Expand the Opportunities for Early-Line Treatment of Multiple Myeloma and the Basic Rationale

Speaker:

Sho Ikeda
(Department of Hematology, Nephrology,and Rheumatology, Akita University Graduate School of Medicine)

Luncheon Seminar3-5

Saturday, September 25 12:00-12:45No.5

Treatment Strategy for DLBCL ~From the Present to the Future~

Sponsor: Genmab K.K

Chair:

Kenji Ishitsuka
(Department of Hematology and Rheumatology, Kagoshima University Hospital)

Speaker:

Ken Omachi
(Department of Hematology & Oncology, Tokai University School of Medicine)

Luncheon Seminar3-6

Saturday, September 25 12:00-12:45No.6

MRD-guided Optimized Treatment in Adult Ph-negative Acute Lymphoblastic Leukemia

Sponsor: Amgen K.K./Astellas Pharma Inc.

Chair:

Naoyuki Uchida
(Toranomon Hospital Hematology)

Speaker:

Koji Nagafuji
(Division of Hematology and Oncology,Department of Medicine,Kurume University School of Medicine)

Luncheon Seminar3-7

Saturday, September 25 12:00-12:45No.7

New findings in Diagnose and Treatment of aHUS -Complement mediated hematological disease-

Sponsor: Alexion Pharma GK

Chair:

Masanori Matsumoto
(Department of Blood Transfusion Medicine, Nara Medical University)

Speaker:

Yoshihiro Fujimura
(Nara Medical University)

Luncheon Seminar3-8

Saturday, September 25 12:00-12:45No.8

Experience of Inotuzumab Ozogamicin Use For Relapse/Refractory ALL

Sponsor: Pfizer Japan Inc.

Chair:

Shingo Yano
(Department of Medicine (Oncology/Hematology), The Jikei University School of Medicine)

Speaker:

Shinsuke Takagi
(Department of Hematology, Toranomon Hospital)

Luncheon Seminar3-9

Saturday, September 25 12:00-12:45No.9

Combination of IMiD and MoAb for relapsed/refractory myeloma

Sponsor: Bristol-Myers Squibb K.K.

Chair:

Ichiro Hanamura
(Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine)

Speaker:

Junya Kuroda
(Division of Hematology and Oncology, Kyoto Prefectural University of Medicine)

Luncheon Seminar3-10

Saturday, September 25 12:00-12:45No.10

Pathophysiology and Treatment Approaches For Lower-Risk MDS

Sponsor: Nippon Shinyaku Co., Ltd.

Chair:

Masahiro Kizaki
(Department of Hematology, Saitama Medical Center, Saitama Medical University)

Speaker:

Takahiro Suzuki
(Department of Hematology, Kitasato University School of Medicine)

Luncheon Seminar3-11 Live Recording On-demand

Saturday, September 25 12:00-12:45No.11

The management of Infection with antibody therapy
-The efficacy of SCIG in the treatment of lymphoma and myeloma-

Sponsor: CSL Behring K.K.

Chair:

Nobuyuki Takayama
(Department of Hematology, Kyorin University School of Medicine)

Speaker:

Tomoki Ito
(Kansai Medical University, First Department of Internal Medicine (Hematology))

Luncheon Seminar3-12

Saturday, September 25 12:00-12:45No.12

Approach to older patients with multiple myeloma considered advance treatment planning

Sponsor: Takeda Pharmaceutical Company Limited

Chair:

Hiroshi Handa
(Department of Hematology, Gunma University Graduate School of Medicine, Gunma, Japan)

Speaker:

Ryosuke Ogawa
(Hematology-Oncology, JCHO Kyushu Hospital, Fukuoka, Japan)

Luncheon Seminar3-13

Saturday, September 25 12:00-12:45No.13

Points of treatment strategy for PTCL

Sponsor: Mundipharma K.K.

Chair:

Toru Kiguchi
(Department of Diabetes, Endocrinology and Hematology, Dokkyo Medical University Saitama Medical Center)

Speaker:

Michihiro Uchiyama
(Department of Hematology, Japanese Red Cross Society Suwa Hospital)

Evening Seminar1-1

Thursday, September 23 17:25-18:10No.1

Clinical development of CAR-T cell therapy for relapsed/refractory DLBCL: Current status and future perspective

Sponsor: Bristol-Myers Squibb K.K.

Chair:

Masayuki Hino
(Department of Hematology, Graduate School of Medicine, Osaka City University)

Speaker:

Shinichi Makita
(Department of Hematology, National Cancer Center Hospital)

Evening Seminar1-2

Thursday, September 23 17:25-18:10No.2

Strategy for management of fungal infections in patients with hematological disease

Sponsor: Sumitomo Dainippon Pharma Co., Ltd.

Chair:

Atsushi Wake
(Dept. of. Hematology, Toranomon Hospital, Kajigaya)

Treatment strategy for fungal infection in febrile neutropenia of hematological disease

Speaker:

Tatsuo Oyake
(Division of Hematology and Oncology, Iwate Medical University)

An appropriate use of antifungals in department of hematology - based on novel evidence -

Speaker:

Koichi Izumikawa
(Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences/Infection Control and Education Center, Nagasaki University Hospital)

Evening Seminar1-3

Thursday, September 23 17:25-18:10No.3

An appropriate medical care snuggling up to hemophiliacs.
-Including the latest evidence on Hemlibra-

Sponsor: Chugai Pharmaceutical Co., Ltd.

Chair:

Jun Yamanouchi
(Division of Blood Transfusion and Cell Therapy, Ehime University Hospital)

Speaker:

Yushi Chikasawa
(Department of Laboratory Medicine, Tokyo Medical University)

Evening Seminar1-4

Thursday, September 23 17:25-18:10No.4

Novel ultrasonographical system makes possible early diagnosis of SOS/VOD and it's real usefulness in clinical practice

Sponsor: Pfizer Japan Inc.

Chair:

Kimikazu Yakushijin
(Department of Medical Oncology and Hematology, Kobe University Hospital)

The road to establishing non-invasive early SOS/VOD diagnosis by ultrasonography

Speaker:

Mutsumi Nishida
(Department of Radiation Oncology, Hokkaido University Hospital)

Usefulness of ultrasonographical SOS/VOD diagnostic system in clinical practice

Speaker:

Junichi Sugita
(Central Clinical Facilities, Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital)

Evening Seminar1-5

Thursday, September 23 17:25-18:10No.5

Updated Treatment Strategy for WM/LPL

Sponsor: ONOPHARMACEUTICALCO.,LTD.

Chair:

Naohiro Sekiguchi
(Hematology Devision, National Hospital Organization Disaster Medical Center)

Speaker:

Wataru Munakata
(National Cancer Center Hospital, Department of Hematology)

Evening Seminar1-6

Thursday, September 23 17:25-18:10No.6

Essential thrombocythemia

Sponsor: Takeda Pharmaceutical Company Limited

Chair:

Keita Kirito
(University of Yamanashi)

Secrets of Management of Essential Thrombocythemia 〜How to use evidence in practice〜

Speaker:

Yuka Sugimoto
(Department of Community Hematology, Mie University / Takeuchi Hospital)

ET and stroke

Speaker:

Kazumi Kimura
(Department of Neurology,Nippon Medical School)

Ⓔ Evening Seminar1-7

Thursday, September 23 17:25-18:10No.7

Treatment strategy of relapsed/refractory follicular Lymphoma

Sponsor: Eisai Co.,Ltd.

Chair:

Koji Izutsu
(Department of Hematology,National Cancer Center Hospital)

Speaker:

Franck Morschhauser
(Groupe de Recherche sur les formes Injectables et les Technologies Associées, CHU de Lille, Université de Lille)

Evening Seminar1-8

Thursday, September 23 17:25-18:10No.8

The practice of treatment with azacitidine for AML

Sponsor: Nippon Shinyaku Co., Ltd.

Chair:

Yasushi Miyazaki
(Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University)

Speaker:

Naoko Hosono
(Department of Blood Transfusion, University of Fukui Hospital)

Ⓔ Evening Seminar1-9

Thursday, September 23 17:25-18:10No.9

Treatment Strategy of Mantle Cell Lymphoma (MCL) and role of Ibrutinib in second line treatment

Sponsor: Janssen Pharmaceutical K.K

Chair:

Kazuhito Yamamoto
(Department of Hematology and Cell Therapy, Aichi Cancer Center)

Speaker:

Pier Luigi Zinzani
(Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy)

Evening Seminar1-10

Thursday, September 23 17:25-18:10No.10

Gaucher's disease and hematological malignancies

Sponsor: Sanofi K.K.

Chair:

Hiroshi Harada
(Department of Hematology, Showa University Fujigaoka Hospital)

Speaker:

Katsuyuki Kito
(Division of Hematology, Department of Internal Medicine, Shiga University of Medical Science)

Evening Seminar1-11 Live Recording On-demand

Thursday, September 23 17:25-18:10No.11

Transforming Homecare for Patients in Hematology
-Challenges and Opportunities for Community Hematologists-

Sponsor: Novartis Pharma K.K.

Chair:

Norimitsu Kadowaki
(Department of Internal Medicine, Division of Hematology,Rheumatology and Respiratory Medicine, Faculty of Medicine, Kagawa University)

Home Care for Hematologic Disorders and Transfusion at Home

Speaker:

Hiroshi Akasaka
(Akasaka Clinic)

Community cooperation of Hematological Diseases -Activities of Hemato-Homecare Network-

Speaker:

Kota Ohashi
(TOTUS Homecare Clinic/NPO Hemato-Homecare Network)

Evening Seminar1-12

Thursday, September 23 17:25-18:10No.12

Changes in PNH
(Paroxysmal Nocturnal Hemoglobinuria) treatment

Sponsor: Alexion Pharma GK

Chair:

Junichi Nishimura
(Department of Hematology and Oncology, Osaka University Graduate School of Medicine)

Speaker:

Ken Ishiyama
(Department of Hematology, Kanazawa University Hospital)

Evening Seminar1-13A

Thursday, September 23 17:25-18:10No.13A

Molecular basis for pathogenesis and progression of MDS

Sponsor: Takeda Pharmaceutical Company Limited

Chair:

Kinuko Mitani
(Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan)

Speaker:

Hideaki Nakajima
(Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Kanagawa, Japan)

Industry Session1-3 Live Recording On-demand

Thursday, September 23 14:00-14:30No.3

Diagnosis and treatment of PNH with bone marrow failure

Sponsor: Alexion Pharma GK

Chair:

Kensuke Usuki
(Department of Hematology, NTT Medical Center Tokyo)

Speaker:

Yasuyoshi Morita
(Department of Hematology and Rheumatology, Kindai University Hospital, Faculty of Medicine)

Industry Session1-4

Thursday, September 23 14:00-14:30No.4

Therapeutic strategy for Primary Central Nervous System Lymphoma

Sponsor: ONOPHARMACEUTICALCO.,LTD.

Chair:

Hirokazu Nagai
(Clinical Research Center National Hospital Organization Nagoya Medical Center)

Speaker:

Fumiyuki Yamasaki
(Hiroshima University Hospital Department of Neurosurgery)

Industry Session1-8

Thursday, September 23 14:00-14:30No.8

Up-to-date overview of the management of febrile neutropenia in adults with hematologic malignancies and hematopoietic cell transplant recipients

Sponsor: Asahi Kasei Pharma Corporation

Chair:

Takehiko Mori
(Department of Hematology, Tokyo Medical and Dental University)

Speaker:

Keiji Okinaka

(General Internal Medicine, National Cancer Center Hospital East , Hematopoietic stem cell transplantation, National Cancer Center Hospital)